chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Wayde Olmsted is a 62 y.o. male was admitted on 8/31/2021 for abdominal pain. On imaging he was found to have The superior mesenteric artery origin is chronically occluded with dense calcifications.  There is a very high-grade stenosis of the proximal celiac artery. General surgery was consulted. Vascular surgery was consulted. IR was consulted.  Initially on clinical monitoring it was suspected that his symptoms are from chronic atherosclerosis of the arteries of gut supply. An attempt was made to stent with no success patient tolerated the procedure and plan was to try the next with different approach to stent. Next morning patient found to be unresponsive, hypotensive, hypoglycemic, RRT was called, upon evaluation patient was only minimally responsive to verbal commands, reponded to painful stimuli with grimacing, pupils were uneven and dilated, breathing was even, abdomen was tender, blood sugar 20-30, bp 70/30, Hb 6.8, Ph 7.2 Patient received if fluid bolus, dextrose, attempts to resuscitate made. Patient transferred to ICU. Intubated in ICU. Discuss with General surgery for possible worsening and Acute abdomen, Discuss with Vascular surgery for revascularization option. Patient went to OR open EX Lap done, Ischemic bowel deemed not salvageable. Patient returned to ICU. Called brother and Sister. Shared thought on treatment at this point would be medically futile and discussed Goals of care. They are on the way to hospital to see him and would express choices for goals of care. Patient coded before family could reach to the hospital. Code went on for more than 10 minutes. Patient was positive for covid. Family reached to the hospital and decided for comfort care measures only. Patient passed away on 9/2/2021.
Tachycardia Narrative:  0758 employee c/o what felt like increased heart rate and then slowed down. Employee stated that he did not eat in AM. VS: T96.8; 120/75; 61; 96% RA. Employee reclined back with feet up an given cranberry juice. 0820 employee stated he felt better after cranberry juice. VS: T96.4 133/79; 54; 96% RA.
I don't know if this is related or not, but it's better to be safe than sorry, right? I've never had any kind of problems with my eyes before, and today while I was at work my left eye started swelling, and now I have this weird bump or bubble that looks like a blister on my eye. I have no idea what it is or where it came from.
Fever up to 101, body aches, joint pains, fatigue, nausea and vomiting.
Information has been received from a 62 year old male consumer with hypertension, "cholesterol" and allergy to antihistamines who on 16-APR-2012 was vaccinated with a dose of zoster vaccine live (Merck) (dose and lot# were unknown). Concomitant therapy included DIAZEPAM. The patient stated that, on 16-APR-2012, after an unspecified length of time after receiving zoster vaccine live (Merck), he experienced diarrhea, he also experienced bruising inside his mouth, on his sternum area and near his pectoral area. On his left side, he also had five quarter-sized bruises. No treatment was given. Blood tests were performed (results unknown). On 18-APR-2012, the patient went to his doctor for medical attention. At the time of reporting, the outcome of both events were unknown. Follow up information was received from the physician which stated that the patient was vaccinated with the first dose of zoster vaccine live (Merck) (lot# 672557/1601AA) on left arm on 16-APR-2012. Then the patient described that on 18-APR-2012, he waking up with bruising on chest and left rib cage. At the time of reporting, the outcome of this event was unknown. It was also reported that the patient did not seek medical attention. Follow up information has been received on 11-FEB-2013 by a physician. The reporter stated that patient was vaccinated with ZOSTAVAX in the left deltoid. Also, it was reported that patient described the experience as wake up with bruising on chest and left rib cage, on 18- APR-2012. The outcome for bruises was reported as recovered. Additional information is not expected.
w/in 1hr p/vax pt started crying & cried 24hrs;temp 103-104 w/APAP;1 time became limp;was oK p/24hrs;
Pediatric dose administered to 41 YO; Pediatric dose administered to 41 YO; First two doses in 2012 and 3rd dose on 28th-Oct-2022; This case was reported by a other health professional via call center representative and described the occurrence of accidental underdose in a 41-year-old male patient who received HBV (Engerix B pediatric) (batch number YM444, expiry date 22nd May 2024) for prophylaxis.   Co-suspect products included hepatitis B vaccine pre-filled syringe device (Engerix B Pre-Filled Syringe Device) injection syringe for prophylaxis.   Previously administered products included Engerix B (1st dose received on 2012) and Engerix B (2nd dose received on 2012).   On 28th October 2022, the patient received the 3rd dose of Engerix B pediatric and Engerix B Pre-Filled Syringe Device. On 28th October 2022, unknown after receiving Engerix B pediatric and Engerix B Pre-Filled Syringe Device, the patient experienced accidental underdose, adult use of a child product and drug dose administration interval too long. On an unknown date, the outcome of the accidental underdose, adult use of a child product and drug dose administration interval too long were unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: GSK Receipt Date: 28-OCT-2022 Reporter's Comment: The reporter was a clinic superviser. The reporter reported that the nurse was inadvertently administered a pediatric dose of Engerix B to the adult patient. The reporter stated that this was the 3rd dose of the patient he had received. The patient was received his first 2 doses in 2012. The reporter stated that the provider ordered for the patient to restart the series. The vaccine administration facility was the same as primary reporter. The reporter did consent to follow up. Additional Supportive Information: The adult patient was administered a pediatric dose of Engerix B, which led to accidental underdose and adult use of a child product. The patient received 3rd dose of Engerix B late than recommended time frame, which led to lengthening of vaccination schedule.
patient fainted after getting vaccine paramedics were called and came to check patient but was not taken to hospital. per patient she was fasting
Per patient, arm is sore, injection site is swollen and bruised, bruising down arm to the elbow, and unable to raise arm over head.
Swollen lymph node on left neck, heavy legs and shooting pain through veins from the growing down to my toes on left side.
Systemic: Other- Hypertension 160/100 and started on blood pressure meds
Developed macular rash over total body (sparing mucus membranes, palms, soles). Took 3-4 weeks to resolve
Information has been received from a physician and a medical assistant concerning a 70 year old white female who "recently," in 2002, was vaccinated with a dose of pneumococcal vaccine 23 polyvalent. The physician  reported that the vaccine was given in an "improper site." Subsequently in 2002, the patient developed a "local reaction" at the injection site including discomfort (previously reported as soreness), erythema (previously reported as redness), and edema. The patient was treated with ice and "antibiotics" (therapy unspecified) and had no sequela. The physician indicated that the patient had a previous exposure to pneumococca; vaccine 23 polyvalent or a related drug five years ago and developed a "one shot reaction" with no sequela which required no medication. The outcome was not reported. The patient sought unspecified medical attention. In follow up, the physician reported that the patient's local erythema and edema had subsided and provided no additional information. No further information is available.
Injected patient, felt bone, pulled needle all the way back Re-adjusted site location and injected patient again and administered vaccine in muscle area Patient did not have any effects during the 15 min wait.
Tenderness at site started the morning following vaccination, which progressed over the next 2-3 days to localized swelling, erythema, warmth, and increased tenderness.
acute myeloid leukemia; This is spontaneous report from a contactable consumer (patient). An 80-year-old female patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE), on 16Jan2021 at 13:00 (at the age of 80-years-old) at single dose in left arm for COVID-19 immunisation. Historical vaccine included first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE), on 28Dec2020 at 13:00 at single dose in left arm for COVID-19 immunisation. The patient was vaccinated at Workplace clinic. No other vaccine was given within 4 weeks prior to the COVID vaccine. The patient has known allergies to penicillin. The patient received no concomitant medications. The patient experienced acute myeloid leukemia. Onset date of the event was reported as 16Feb2021 at 08:00. The event resulted in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care, hospitalization, Life threatening illness (immediate risk of death from the event). The paitent was hospitalized for 7 days and was treated with Leukopheresis, Hydrea, Chemotherapy, Vancomycin. The patient had not recovered. Prior to vaccination, the patient was not diagnosed with COVID-19 and since the vaccination, has not been tested for COVID-19.  Information about batch/lot number has been requested.
A report has been received from a Health Professional concerning a 5 year old, subject of unknown gender. who had been receiving FLUMIST QUADRIVALENT (intranasal). FLUMIST QUADRIVALENT started on an unknown date. The nurse reported that they inadvertently administered expired FLUMIST QUADRIVALENT to the patient which started on 14-Jan-2014. The outcome of the event of expired FLUMIST is unknown. The report was considered to be non-serious by the reporter.
Patient reported low-grade fever within hours after vaccination, as well as itchy skin around the site of injection and a few hives and redness.
Local effects of vaccines (L) thigh recommendations given include warm compress and clean area well TID. Pt's mother was advised if there is no improvement also instructed to call if new or worsening symptoms develop.
"Pfizer-BioNTech Covid-19 Vaccine EUA Six days after after I received the second dose of the vaccine I started having a right hip pain. The next day, I started having  constant low back pain, bilateral hip pain, left shoulder pain and pain  below both thumbs. Aleve  relieved the pains only for 6 hours and then start again. My sleep was so disrupted for 7 days. I finally say  Dr. on 1/19/2021
Had usual soreness for day or 2 after shot that went away.  On day 6, itching starting and on  day 7 swelling started involving whole outer side of upper arm.  Contacted doctor on day 8 and was prescribed Methyprednisonal Dose Pak 4mg and Benedryl 25mg 4x/day.  Swelling started to go down within a few hours of dosing but then widespread redness appeared. The redness was mildly better but as of today, day 12, it is still there and has migrated to my bicep and actually has ridges of red swelling.
Six (6) hours after injection was administered I developed chills that lasted throughout the next day.  Upset stomach that lasted 24 hours.  Severe headache, tightness of mandible and stiff neck that also lasted for approximately 3 days.  Shoulder pain that radiated to bilateral elbow area which lasted for four days.  Covid arm.  There was a 2 inch radius of swelling , tenderness, redness  from injection site.  Covid arm lasted for one full week and tenderness, itching experience d for a week and a half.
Fever of 101.3, body aches and headache. Lasted 6-9hours. Treated with Tylenol and Ibuprofen.
When bandaids removed from shots, the next day, mother noticed bumpy round area to skin and right leg. Mother found areas gradually up on both arms and legs, rough and painful areas of skin, not on trunk. Continues to be present.
A report has been received from a Health Professional concerning an 11 year old, female subject, who had been receiving FLUMIST (Intranasal). FLUMIST (Intranasal) started on 27-Jan-2014. It was reported that patient was inadvertently administered expired FLUMIST on 27-Jan-2014. The outcome of the event of INADVERTENTLY ADMINISITERED EXPIRED FLUMIST is unknown. The report was considered to be non-serious.
Since the second vaccination dose, I have been waking up in the morning with  sore, stiffened joints in my hands.  For the first week the finger tips were sore, tingling, and painful.  Just a very strange feeling , as if full circulation was somehow shunted or compromised. Then in the following weeks it spread to my entire hands.  A few days last week my forearms were very sore and the hands painful.  This has never happened to me ever before in my life.  I need to rub my fingers and hands throughout the day to combat this; at times I apply Tiger Balm for relief. I have now significantly increased my exercise regimen (including yoga).
Received vaccine on 2/1/03. Noticed swelling on the night of the 2nd, I am experiencing aching pains, itching, swelling that is moving down my arm, tightness.
COVID-19 Vaccine EUA; Eight days after receiving vaccine the swelling and redness and itching at the injection site returned.  It had previously resolved three days after the injection.  I am also feeling somewhat itchy.  I first noticed the redness and swelling when I woke up in the morning.  It is now 11PM and I took 2x25mg Benadryl.  No other treatment so far.
Patient was incorrectly administered Moderna vaccine dose of 0.5ML in place of the 0.25mL indicated for Booster dose.
Vaccine administered to patient <18 yrs old; This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Vaccine administered to patient <18 yrs old) in a 16-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 08B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 14-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 14-Apr-2021, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Vaccine administered to patient <18 yrs old). On 14-Apr-2021, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Vaccine administered to patient <18 yrs old) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No relevant concomitant medications were reported.   Treatment information was not provided.
Within 24 hours pain in left side of left chest, in 48 hours pain on full left side of chest, within 72 hours pain through entire chest.  Hospitalized within 72 hours, chest pains, catheterized within 120 hours, had a blood clotting issue, put into medically induced coma for three and a half days, followed by a pulmonary embolism and four (4) clogs, two (2) in either leg, within two weeks.  Hospitalized twice, currently on three blood thinners, a beta blocker,  pepcid, a statin, and one other.  Expected to be on three blood thinners for at least three (3), most likely six (6) months.  Start cardiac rehab on 5/19/21.  Have chronic cough and chest discomfort.  Expected recovery time: six (6) months.
Flu Luke symptoms. Chills, fever exceeding 104, body aches and soreness, head ache.
She is feeling a bad reaction over the booster shot from Pfizer shot; She is feeling a bad reaction over the booster shot from Pfizer shot; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) for a Pfizer sponsored program. The reporter is the patient. A 80 year-old female patient received bnt162b2 (BNT162B2), administered in arm left (Lot number: FH8030) at the age of 80 years as dose number unknown (booster), single for covid-19 immunisation. The patient's relevant medical history was not reported. Concomitant medication(s) included: PROZAC; BUSPAR. Vaccination history included: Covid-19 vaccine (Dose 1, MANUFACTURER UNKNOWN), for covid-19 immunisation; Covid-19 vaccine (Dose 2, MANUFACTURER UNKNOWN), for covid-19 immunisation. The following information was reported: IMMUNISATION (non-serious), FEELING ABNORMAL (non-serious), outcome "unknown" and all described as "She is feeling a bad reaction over the booster shot from Pfizer shot".  Additional information: She took an Advil which was expired 2 years ago, 200 mg 1 tablet. Reporter stated lot number as PAA023944, but now was seeing the another number and do not know which was correct. On the side of the bottle it says expiration 02-20 and there was a number above it that was different than F99280.  Follow-up attempts completed. No further information expected
This spontaneous report was received from a certified medical assistant refers to an unspecified patients of unknown age. On an unknown date, the patients were vaccinated with unsoecified doses of improperly stored GARDASIL 9, 1024993, 17-OCT-2017. No adverse events were reported. Temperature of 49.3 F for 24 hours and there was no previous temperature excursion. This is one of the 4 reports received from the same reporter. Additional information has been requested.
Chills, body aches, severe malaise, lethargy, headache, neasuea, joint pain, lightheaded, flu symptoms for three days
Redness Swelling (egg-shaped, hard raised area) of arm, tingling, warmth
Information has been received from a RN reporting on behalf of an MD concerning a 19 month old male pt who on 03Apr2003 was vaccinated in the right arm with a dose of varicella virus vaccine live. There was no illness at the time of vaccination. On 17Apr2003 in the AM, a follow up visit indicated that the pt had 2 red papules at the site of injection. There was no relevant diagnostic data. It was also noted that the pt was otherwise unremarkable. Unspecified medical attention was sought. Subsequently, the pt recovered. There was no product quality complaint involved. No further information is expected.
left arm hurt; felt burning and itching mainly on my chest pretty severe; felt burning and itching mainly on my chest pretty severe and a randomly itching sensation through my entire body; explain that would be that it felt like a bunch of fleas attacked me and bit me in random order; This is a spontaneous report from a contactable consumer(patient). A patient of unspecified age and gender received bnt162b2 (BNT162B2, Solution for injection, Batch/Lot number was not reported, Expiry date: unknown), dose 2 via an unspecified route of administration on 25May2021 as dose 2, single for covid-19 immunisation. Medical history included varicella. There were no concomitant medications. Historical vaccine included bnt162b2 (BNT162B2, Batch/Lot number was not reported, Expiry date: unknown), dose 1 via an unspecified route of administration, administered in Arm Left on 05May2021 as dose 1, single for covid-19 immunisation. About 8 hours after the vaccination left arm hurt for about 2 days and that was all the patient experienced after first dose and received Shingrix on an unspecified date for an unspecified indication. The patient experienced about 8 hours after left arm hurt, and 2 hours after that felt burning and itching mainly on chest pretty severe, and a randomly itching sensation through entire body, it felt like a bunch of fleas attacked and bit in random order. The patient stated once again about 8 hours later my left arm hurt and 2 hours after that felt burning and itching mainly on chest. Pretty severe and a randomly itching sensation through my entire body. The best way to explain that would be that it felt like a bunch of fleas attacked me and bit me in random order. The patient scratched the "attacked" spot lightly and it stopped itching but would pop up on other parts of my body. The first day was very intense, the second day not too bad the third day it faded out and that was It certainly was not the worst experience after the vaccination but a very uncomfortable one. Saturday, 24July2021 this scenario repeated itself in the same order. For no reason, The patient went through the same ordeal severe itching on the chest throughout the body for almost 3 days, and then it disappeared. And nothing triggered it. No vaccination or any other outside influence. The patient discovered a very unique comparison in my health history which may shed some light on this situation. At the tender age of 40, the patient was diagnosed with chickenpox. The symptoms experienced were very similar to what described above. Itching and discomfort at the same body parts. Ca. 20 years later heard about shingle shots. As the pharmacist gave the injection, the patient felt a brief itching sensation, exactly the same location where had the chickenpox, mainly on the chest and all over the body. That lasted only a few minutes and then disappeared. It almost felt as if the body "remembered" where the virus was located. The outcome of the events was unknown.
pt had a positive COVID test on 12/29/21, was treated outpatient with azithromycin, Zofran, Flovent, monoclonal antibodies, Medrol Dosepak, albuterol MDI; had worsening SOB and was given Levaquin; still had worsening SOB and was given IV Rocephin and steroid injections; on 2/22/22 pt was admitted to Hospital for 2 days; dc'd to home with O2 supplementation and dexamethasone; presents to ED on 2/9/22 with worsening SOB and hypoxia; O2 supplementation; (history of lymphoma); IgG and Igm deficiency; given high dose steroids then tapered off due to no improvement; O2 requirement increased to a need of high flow via NC; DNR; pt's condition continued to worsen and he was made comfort measures; he passed away in the hospital
Patient called stating after getting flu vaccine yesterday that the site was extremely sore, he had a fever and felt chilled.
Initial and follow up information has been received from a medical assistant and a physician through the Merck Pregnancy Registry for GARDASIL concerning a 16 year old female with no previous pregnancies and no significant past medical history who on 31-Jan-2007, 03-Apr-2007 and 25-Oct-2007 was vaccinated intramuscularly with first, second and third 0.5ml doses, respectively, of GARDASIL (lot #s: 653937/0637U, 654389/0961F, 658560/1062U) while pregnant.  The patient's last menstrual period (LMP) was 15-AUG-2007 with an estimated delivery date of 15-MAY-2008.  The patient took prenatal vitamins (unspecified) one daily from October 2007 to May 2008.  On 10-JAN-2008 and 14-MAY-2008 the patient underwent routine ultrasound which were normal per patient.  On 15-MAY-2008 at 40-41 weeks from the LMP, the patient delivered a normal liveborn male, weighing 7lbs, 4 ozs., length: 21 in; head circumference: 14 in.  On approximately 15-MAY-2008, after delivery the patient experienced "eclampsia-seizure xl".  Upon internal review, the patient's "eclampsia-seizure" was considered to be an other important medical event.  Additional information is not expected.
Angioedema swelling in lips, tingling in face unilateral facial paralysis Narrative: